MedPath

Effect of Weight Loss and Exercise on Liver and Muscle Fat in Obese Elderly

Phase 3
Completed
Conditions
Obesity
Interventions
Behavioral: weight loss
Behavioral: weight loss and exercise
Registration Number
NCT00779207
Lead Sponsor
Washington University School of Medicine
Brief Summary

The purpose of this study is to determine the effect of weight loss and exercise on liver and muscle fat.

Detailed Description

Obesity causes serious medical complications and impairs quality of life. Moreover, both aging and obesity cause metabolic and physical dysfunction. The primary objectives of the proposed research are to evaluate the independent and combined effects of weight loss and exercise on Intrahepatic and Intramyocellular fat in obese elderly men and women. The central hypothesis is that in obese elderly subjects, weight loss will improve metabolic and physical function while the addition of exercise will not only augment improvement in these outcomes, but also attenuate the adverse effects of weight loss on bone and muscle masses. To test this hypothesis, 20 elderly (65-85 years old) obese men and women (body mass index \[BMI\] \> 30 kg/m2) with physical frailty will be randomized to 2 treatment groups: 1)10% weight loss, 2) 10% weight loss plus exercise training.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Obese (BMI 30 or greater)
  • Elderly (age 65 years or older)
Exclusion Criteria
  • Major chronic disease or any condition that would interfere with exercise or dietary restriction, in which exercise or dietary restriction are contraindicated, or that would interfere with interpretation of results. Examples include cardiopulmonary disease, unstable disease, severe orthopedic or neuromuscular impairments, dementia, history of malignancy during the past 5 years

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1weight lossweight loss
2weight loss and exerciseWeight loss and exercise
Primary Outcome Measures
NameTimeMethod
Intrahepatic fat Intramyocellular fat6-month
Secondary Outcome Measures
NameTimeMethod
Insulin sensitivity Physical Function6-month

Trial Locations

Locations (1)

Washington University School of Medicine

🇺🇸

St. Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath